Dr. Maha Al-Mozaini has extensive clinical infectious disease research expertise from her postgraduate studies at Imperial College School of Medicine, UK, and Harvard Medical School, US. With over 27 years of commitment to research, she has implemented strategies to enhance health and scientific programs nationwide. Recently, she joined the Research, Development, and Innovation Authority to lead health-related projects aligned with Vision 2030. Her interests span research, development, innovation, health, science investments, and biotech, reflecting her dedication to advancing healthcare and scientific endeavors in Saudi Arabia.